NEW YORK (TheStreet) -- Shares of Walgreens Boots Alliance (WBA) are advancing, up 0.53% to $84.73 on Tuesday after Leerink raised its price target to $95 from $85 while maintaining its "outperform" rating.
The firm also increased 2015 earnings estimates to $3.75 per share from $3.65.
The Pharmaceutical Wholesale segment will likely see slow and steady growth with less international drug inflation than in the U.S., Leerink noted.
"While it will take time for changes to translate into an acceleration of health and beauty sales, we expect meaningful embedded growth from ongoing joint purchasing synergies, private label brand cross selling, further international expansion through acquisitions, and cost cutting efforts," Leerink analysts said.
Walgreens Boots Alliance, based in Deerfield, IL, is a retail pharmacy holding company that owns Walgreens, Boots, and a number of pharmaceutical manufacturing, wholesale and distribution companies.
Separately, TheStreet Ratings team rates WALGREENS BOOTS ALLIANCE INC as a Buy with a ratings score of A+. TheStreet Ratings Team has this to say about their recommendation:
"We rate WALGREENS BOOTS ALLIANCE INC (WBA) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity."